271 related articles for article (PubMed ID: 32741485)
1. Aggressive Pituitary Adenomas and Carcinomas.
Ilie MD; Jouanneau E; Raverot G
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):505-515. PubMed ID: 32741485
[TBL] [Abstract][Full Text] [Related]
2. World Health Ozganization 2017 Classification of Pituitary Tumors.
Lopes MBS
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):375-386. PubMed ID: 32741477
[TBL] [Abstract][Full Text] [Related]
3. Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016.
McCormack A; Dekkers OM; Petersenn S; Popovic V; Trouillas J; Raverot G; Burman P;
Eur J Endocrinol; 2018 Mar; 178(3):265-276. PubMed ID: 29330228
[TBL] [Abstract][Full Text] [Related]
4. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.
Dai C; Liang S; Sun B; Kang J
Front Endocrinol (Lausanne); 2020; 11():608422. PubMed ID: 33362722
[TBL] [Abstract][Full Text] [Related]
5. Definition and diagnosis of aggressive pituitary tumors.
Kasuki L; Raverot G
Rev Endocr Metab Disord; 2020 Jun; 21(2):203-208. PubMed ID: 31808044
[TBL] [Abstract][Full Text] [Related]
6. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas.
Raverot G; Burman P; McCormack A; Heaney A; Petersenn S; Popovic V; Trouillas J; Dekkers OM;
Eur J Endocrinol; 2018 Jan; 178(1):G1-G24. PubMed ID: 29046323
[TBL] [Abstract][Full Text] [Related]
7. Malignant pituitary tumours.
Kaltsas GA; Grossman AB
Pituitary; 1998 Apr; 1(1):69-81. PubMed ID: 11081185
[No Abstract] [Full Text] [Related]
8. Approach to the Treatment of a Patient with an Aggressive Pituitary Tumor.
Lin AL; Donoghue MTA; Wardlaw SL; Yang TJ; Bodei L; Tabar V; Geer EB
J Clin Endocrinol Metab; 2020 Dec; 105(12):3807-20. PubMed ID: 32930787
[TBL] [Abstract][Full Text] [Related]
9. [Aggressive pituitary adenoma and pituitary carcinoma].
Tóth M
Orv Hetil; 2023 Jul; 164(30):1167-1175. PubMed ID: 37516994
[TBL] [Abstract][Full Text] [Related]
10. Aggressive pituitary tumours and carcinomas: two sides of the same coin?
Trouillas J; Burman P; McCormack A; Petersenn S; Popovic V; Dekkers O; Raverot G
Eur J Endocrinol; 2018 Jun; 178(6):C7-C9. PubMed ID: 29588294
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of aggressive pituitary tumors (and its challenges).
Dekkers OM; Karavitaki N; Pereira AM
Rev Endocr Metab Disord; 2020 Jun; 21(2):209-212. PubMed ID: 32361816
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pituitary carcinomas and atypical pituitary adenomas: a review.
Hirohata T; Ishii Y; Matsuno A
Neurol Med Chir (Tokyo); 2014; 54(12):966-73. PubMed ID: 25446382
[TBL] [Abstract][Full Text] [Related]
13. Invasive pituitary adenomas: significance of proliferation parameters.
Amar AP; Hinton DR; Krieger MD; Weiss MH
Pituitary; 1999 Aug; 2(2):117-22. PubMed ID: 11081161
[TBL] [Abstract][Full Text] [Related]
14. Pituitary Tumors Centers of Excellence.
Frara S; Rodriguez-Carnero G; Formenti AM; Martinez-Olmos MA; Giustina A; Casanueva FF
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):553-564. PubMed ID: 32741488
[TBL] [Abstract][Full Text] [Related]
15. Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician's questions.
Trouillas J; Jaffrain-Rea ML; Vasiljevic A; Dekkers O; Popovic V; Wierinckx A; McCormack A; Petersenn S; Burman P; Raverot G; Villa C
Rev Endocr Metab Disord; 2020 Jun; 21(2):243-251. PubMed ID: 32504268
[TBL] [Abstract][Full Text] [Related]
16. Refractory pituitary adenoma: a novel classification for pituitary tumors.
Dai C; Feng M; Liu X; Ma S; Sun B; Bao X; Yao Y; Deng K; Wang Y; Xing B; Lian W; Zhong D; Ma W; Wang R
Oncotarget; 2016 Dec; 7(50):83657-83668. PubMed ID: 27845901
[TBL] [Abstract][Full Text] [Related]
17. Pituitary carcinoma: diagnosis and treatment.
Lopes MB; Scheithauer BW; Schiff D
Endocrine; 2005 Oct; 28(1):115-21. PubMed ID: 16311418
[TBL] [Abstract][Full Text] [Related]
18. Aggressive pituitary adenomas--diagnosis and emerging treatments.
Di Ieva A; Rotondo F; Syro LV; Cusimano MD; Kovacs K
Nat Rev Endocrinol; 2014 Jul; 10(7):423-35. PubMed ID: 24821329
[TBL] [Abstract][Full Text] [Related]
19. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
[TBL] [Abstract][Full Text] [Related]
20. Multimodality treatment for invasive pituitary adenomas.
Hornyak M; Couldwell WT
Postgrad Med; 2009 Mar; 121(2):168-76. PubMed ID: 19332975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]